OBJECTIVE: This study aimed to determine the effects of humanlike Western and Mediterranean diets on caloric intake, obesity, metabolism, and hepatosteatosis in an established nonhuman primate model of obesity, cardiometabolic syndrome, type 2 diabetes, and atherosclerosis. METHODS: A 38-month, randomized, preclinical, nonhuman primate primary prevention trial of 38 socially housed, middle-aged adult females was conducted. The monkeys were characterized during a 7-month baseline phase while consuming chow and then randomized to either Western or Mediterranean diets; the groups were balanced on baseline characteristics. Western and Mediterranean diets were formulated to closely reflect human diets, matched on macronutrient content, with protein and fat derived largely from animal sources in the Western diet and plant sources in the Mediterranean diet. Food consumption, activity levels, energy expenditure, body composition, carbohydrate metabolism, and hepatosteatosis were measured during baseline and treatment phases. RESULTS: The Western diet increased caloric intake for the first 6 months and body fat, activity, energy expenditure, insulin resistance, and hepatosteatosis after 2.5 years, whereas the Mediterranean diet reduced triglyceride levels. CONCLUSIONS: This is the first report of differential caloric intake and obesity with long-term consumption of a Western versus Mediterranean diet under controlled experimental conditions and the first experimental evidence that a Mediterranean diet protects against hepatosteatosis compared with a Western diet.
RCT Entities:
OBJECTIVE: This study aimed to determine the effects of humanlike Western and Mediterranean diets on caloric intake, obesity, metabolism, and hepatosteatosis in an established nonhuman primate model of obesity, cardiometabolic syndrome, type 2 diabetes, and atherosclerosis. METHODS: A 38-month, randomized, preclinical, nonhuman primate primary prevention trial of 38 socially housed, middle-aged adult females was conducted. The monkeys were characterized during a 7-month baseline phase while consuming chow and then randomized to either Western or Mediterranean diets; the groups were balanced on baseline characteristics. Western and Mediterranean diets were formulated to closely reflect human diets, matched on macronutrient content, with protein and fat derived largely from animal sources in the Western diet and plant sources in the Mediterranean diet. Food consumption, activity levels, energy expenditure, body composition, carbohydrate metabolism, and hepatosteatosis were measured during baseline and treatment phases. RESULTS: The Western diet increased caloric intake for the first 6 months and body fat, activity, energy expenditure, insulin resistance, and hepatosteatosis after 2.5 years, whereas the Mediterranean diet reduced triglyceride levels. CONCLUSIONS: This is the first report of differential caloric intake and obesity with long-term consumption of a Western versus Mediterranean diet under controlled experimental conditions and the first experimental evidence that a Mediterranean diet protects against hepatosteatosis compared with a Western diet.
Authors: Jenny L Gonzalez-Armenta; Zhengrong Gao; Susan E Appt; Mara Z Vitolins; Kristofer T Michalson; Thomas C Register; Carol A Shively; Anthony J A Molina Journal: J Nutr Date: 2019-09-01 Impact factor: 4.798
Authors: Marnie G Silverstein-Metzler; Brett M Frye; Jamie N Justice; Thomas B Clarkson; Susan E Appt; J Jeffrey Carr; Thomas C Register; Mays Albu-Shamah; Hossam A Shaltout; Carol A Shively Journal: Psychoneuroendocrinology Date: 2022-02-26 Impact factor: 4.905
Authors: Tiffany M Newman; Carol A Shively; Thomas C Register; Susan E Appt; Hariom Yadav; Rita R Colwell; Brian Fanelli; Manoj Dadlani; Karlis Graubics; Uyen Thao Nguyen; Sivapriya Ramamoorthy; Beth Uberseder; Kenysha Y J Clear; Adam S Wilson; Kimberly D Reeves; Mark C Chappell; Janet A Tooze; Katherine L Cook Journal: Microbiome Date: 2021-05-05 Impact factor: 14.650
Authors: Brett M Frye; Suzanne Craft; Thomas C Register; Rachel N Andrews; Susan E Appt; Mara Z Vitolins; Beth Uberseder; Marnie G Silverstein-Metzler; Haiying Chen; Christopher T Whitlow; Jeongchul Kim; Richard A Barcus; Samuel N Lockhart; Siobhan Hoscheidt; Brandon M Say; Sarah E Corbitt; Carol A Shively Journal: Alzheimers Dement Date: 2020-12-03 Impact factor: 21.566
Authors: Michael J Butler; Nicholas P Deems; Stephanie Muscat; Christopher M Butt; Martha A Belury; Ruth M Barrientos Journal: Brain Behav Immun Date: 2021-08-20 Impact factor: 7.217
Authors: K Allison Amick; Gargi Mahapatra; Jaclyn Bergstrom; Zhengrong Gao; Suzanne Craft; Thomas C Register; Carol A Shively; Anthony J A Molina Journal: Am J Physiol Endocrinol Metab Date: 2021-09-27 Impact factor: 4.310
Authors: Joseph M Elsakr; Sifang Kathy Zhao; Valerie Ricciardi; Tyler A Dean; Diana L Takahashi; Elinor Sullivan; Stephanie R Wesolowski; Carrie E McCurdy; Paul Kievit; Jacob E Friedman; Kjersti M Aagaard; Digna R Velez Edwards; Maureen Gannon Journal: Sci Rep Date: 2021-06-21 Impact factor: 4.996